Poster Abstract Session:
69. Respiratory Infections: Viral
Thursday, October 4, 2018: 12:30 PM-1:45 PM
Room: S Poster Hall

Tracks: Epidemiology and Infection Control, Adult ID


Presentations:
714
Predictors of Influenza-Associated Hospitalization and Pneumonia in a Pediatric Population in Bangkok, Thailand
Ali Sawani, BS; Detchvijitr Suwanpakdee, MD; Veerachai Watanaveeradej, MD; Alden Weg, MD; Damon Ellison, PhD; Chonticha Klungthong, PhD; Thipwipha Phonpakobsin, PhD; Phirangkul Kerdpanich, MD; Danabhand Phiboonbanakit, MD; Robert Gibbons, MD; Stefan Fernandez, PhD; Louis Macareo, MD, JD, MPH; In Kyu Yoon, MD; Rick Jarman, PhD; Sriluck Simasthien, MD; Kathryn Anderson, MD, PhD, MSPH
715
Increase in Reported Respiratory Syncytial Virus Cases among Adults in the Minneapolis-St. Paul Metropolitan Area, 2014-2018
Kathryn Como-Sabetti, MPH; Erica Bye, MPH; Anna Strain, PhD; Melissa McMahon, MPH; Ruth Lynfield, MD, FIDSA
Posters
  • RSV Poster IDWeek Final.pdf (445.8 kB)
  • 716
    Molecular epidemiology of respiratory syncytial virus in children and adults in Seattle, WA
    Emily Scott, BS, BA; Jane Kuypers, PhD; Michael L. Jackson, PhD, MPH; Helen Chu, MD MPH
    Posters
  • IDSAposter_KPW_092518.pdf (1.2 MB)
  • 717
    Cumulative Incidence of Asthma/Wheezing among Neonates/Infants/Toddlers Clinically Diagnosed with Respiratory Syncytial Virus Infection in the United States: a Retrospective Database Analysis.
    Veronique Wyffels, PharmD; Maartje Smulders, MSc; Sandra Gavart, MSc MBA; Debasish Mazumder, PhD; Rohit Tyagi, MPH; Nikhil Gupta, BTech; Roman Fleischhackl, MD
    718
    Viral coinfection and nasal cytokines in children with acute bacterial sinusitis (ABS)
    Santiago Lopez, MD; Judith M. Martin, MD; Monika Johnson, BS; John V. Williams, MD; Nader Shaikh, MD
    719
    The Respiratory Pathogen Panel and Antibiotic Utilization in the Emergency Department
    Daniel Taupin, MD; Anna Stachel, MPH, CIC; Dan Ding, MA; Sarah Hochman, MD; Michael Phillips, MD
    Posters
  • DTaupin_IDWPOSTER.pdf (350.0 kB)
  • 720
    Respiratory and Non-Respiratory Complications among Patients Hospitalized with Influenza, FluSurv-NET, 2016–17
    Shikha Garg, MD, MPH; Charisse Nitura Cummings, MPH; Alissa O'Halloran, MSPH; Pam Daily Kirley, MPH; Rachel Herlihy, MD MPH; Kimberly Yousey-Hindes, MPH, CPH; Maya Monroe, MPH; Seth Eckel, MPH; Melissa McMahon, MPH; Kathy Angeles, MPH; Alison Muse, MPH; Nancy M. Bennett, MD; Laurie Billing, MPH; Ann Thomas, MD, MPH; H. Keipp Talbot, MD, MPH; Andrea George, MPH; Evan J. Anderson, MD; Carrie Reed, DSc, MPH
    721
    Clinical Respiratory Syndromes and Association with Influenza Clinical Diagnostic Testing and Antiviral Treatment among Children Hospitalized with Acute Respiratory Illness, 2015-2016
    Angela P. Campbell, MD, MPH, FPIDS, FIDSA; Brian Rha, MD, MSPH; Constance Ogokeh, MPH; Janet Englund, MD, FIDSA; Natasha B. Halasa, MD, MPH, FPIDS; Rangaraj Selvarangan, PhD; Mary A. Staat, M.D., M.P.H.; Geoffrey A. Weinberg, MD, FIDSA, FPIDS; Parvin H. Azimi, MD; Julie A. Boom, MD; Monica McNeal, MS; Leila C. Sahni, MPH; Monica Nayakwadi Singer, MD, MPH; Peter G. Szilagyi, MD, MPH; Christopher J. Harrison, M.D., FAAP, FPIDS; Eileen J. Klein, MD, MPH; Joana Yu, MPH; Daniella Figueroa-Downing, MPH; Daniel C. Payne, PhD, MSPH; Alicia M. Fry, MD, MPH
    722
    Normal clinical signs and duration of antibiotics in hospitalized patients with pneumonia
    Aileen Ochoa, MPH; Wenjing Ji, MS; Cara Smith, MPH; Chanu Rhee, MD, MPH; Michael Klompas, MD, MPH
    723
    Validation of a Wild-Type Influenza A/Texas-like H3N2 Human Challenge Model with Comparison to the Validated A(H1N1)pdm09 Model
    Alison Han, MD, MS; Lindsay Czajkowski, MSN, NP-C; Amanda Donaldson, BSN; Holly Ann Baus, RN, MSN; Susan Reed, BA, CRC; Rani Athota, PhD; Tyler Bristol, BS; Luz Angela Rosas, MS, MLS(ASCP)CM; Adriana Cervantes-Medina, BS; Jeffery K. Taubenberger, MD, PhD; Matthew J. Memoli, MD, MS
    Posters
  • IDWeek2018_Han.pdf (2.2 MB)
  • 724
    Neurologic complications in hospitalized pediatric patients with influenza infection - A multicenter retrospective study in Korea
    Gwang-Jun Choi, MD; Ji Young Park, MD; Joon-Sik Choi, MD; Bitna Kim, RN; Sae Rom Choi, MD; Dong Sub Kim, MD; Ji-Man Kang, MD, PhD; Jun Wha Lee, MD; Young-Jong Woo, MD, PhD; Jeehun Lee, MD, PhD; Yae-Jean Kim, MD, PhD
    725
    Clinical Outcomes of Elderly Individuals Presenting with Acute Respiratory Infections
    Allison Bloom, BA; Sunil Suchindran, PhD; Micah T. Mcclain, MD, PhD
    726
    Viral Genomic Load, Cytokine Profiles and Life-Threatening Respiratory Syncytial Virus Infection in Previously Healthy Infants.
    Fausto Martin Ferolla, MD; Ana Caratozzolo, PhD; Analía Toledano, PhD; Cecilia Anselmino, MD; Carlos Mauricio Vergara Lobo, MD; Maria Agustina Chiormi, MD; Gabriela Visingardi, MD; Patricia Ratto, MD; Graciela Theiler, PhD; Pablo Neira, MD; Mónica Dastugue, MD; Normando Mascardi, MD; Maria Marta Contrini, MD; Eduardo Lopez, MD
    Posters
  • Poster RSV IDweek2018 final.pdf (783.1 kB)
  • 727
    Evaluation of Antibiotic Prescribing Practices for Upper Respiratory Infections in the Adult and Pediatric Emergency Departments
    Megan Lim, PharmD; Lindsay Petty, MD; Nicholas Dillman, PharmD; Pamela Walker, PharmD; Jerod Nagel, PharmD, BCPS
    728
    Regional Validation of Distinct RSV Seasonality Thresholds for Antigen and PCR Testing
    Christopher S. Ambrose, MD, MBA; Lisa L Steed, PhD; Michael Brandon, BSMT (ASCP); Kara Frye, MS, MT (ASCP); Gina Thomson, BS, MT
    730
    Hospital Readmissions following Laboratory-confirmed Influenza
    David Dobrzynski Jr., MD; Danielle Ndi, MPH; Tiffanie Markus, PhD; Yuwei Zhu, MS; William Schaffner, MD, FIDSA, FSHEA; H. Keipp Talbot, MD, MPH
    732
    Description of Diagnoses and Antibiotic Management of Otitis Media and Otitis Externa in Adults
    Benjamin Pontefract, PharmD; Karl Madaras-Kelly, PharmD, MPH; McKenna Nevers, MS; Katherine Fleming-Dutra, MD; Matthew Samore, MD, FSHEA
    733
    Incidence and Evaluation of the Change in Functional Status Associated with Respiratory Syncytial Virus Infection in Hospitalized Older Adults
    Angela Branche, MD; Evelyn Granieri, MD, MPH; Edward Walsh, MD, FIDSA; Lynn Finelli, DrPH; William Greendyke, MD; Ann R. Falsey, MD; Angela Barrett, BA; Celibell Vargas, MD; Lisa Saiman, MD, MPH
    Posters
  • IDWeek 2018 Poster.pdf (436.6 kB)
  • 735
    Severity and Healthcare Costs of Respiratory Syncytial Virus Hospitalizations in US Preterm Infants Born at 29-34 Weeks Gestation: 2014–2016
    Mitchell Goldstein, MD; Leonard R. Krilov, MD; Jaime Fergie, MD; Christopher S. Ambrose, MD, MBA; Sally Wade, MPH; Amanda Kong, MPH; Lance Brannman, PhD
    736
    Incidence and Etiology of Community-Acquired Pneumonia Requiring Hospitalization among American Indian/Alaskan Native Adults.
    Konrad Kross, DO; Whitney Essex, Advanced Registered Nurse Practitioner; David Gahn, MD, MPH; Jorge Mera, MD
    Posters
  • Pneumonia Poster v3 - final.pdf (402.6 kB)
  • 738
    Role of respiratory syncytial virus and Mycoplasma pneumoniae in pediatric community-acquired lower respiratory tract infections
    Sanchit Kumar, MBBS, MD(Student); Anita Chakravarti, MD; Surinder Kumar, MD;DNB;MNAMS; Seema Kapoor, MD
    739
    Middle East Respiratory Syndrome Coronavirus Infection Profile in Qatar: A 7-year retrospective study.
    Nada Elmaki, MD; Fatma Ben Abid, MD; Elmubasher Farag, MD; Hussam Alsoub, Senior Consultant; Hafedh Ghazouani Ghazouani, MSc; Mulham Mohed Saleh, MD; Khalid M. Dousa, MD, FACP, CABIM; Abdullatif Al-Khal, MD senior consultant; Samar Mahmoud A. Hashim, MD; Muna Al- Maslamani, MBBS, CABMS, MSc HCM- RCSI
    Posters
  • IDSA_poster_4_10_2018_Fatma.pdf (313.3 kB)
  • 740
    Impact of the 2014 American Academy of Pediatrics Guidance on Respiratory Syncytial Virus Hospitalization Rates for Preterm Infants <29 Weeks Gestational Age at Birth: 2012–2016
    Mitchell Goldstein, MD; Leonard R. Krilov, MD; Jaime Fergie, MD; Lance Brannman, PhD; Christopher S. Ambrose, MD, MBA; Sally Wade, MPH; Amanda Kong, MPH
    741
    Impact of Adenovirus Co-detections on Illness Severity.
    Varvara Probst, MD; Bhinnata Piya, MPH; Laura Stewart, PhD; Susan Gerber, MD; Brian Rha, MD, MSPH; Joana Yu, MPH; Suman Das, PhD; Angela P. Campbell, MD, MPH, FPIDS, FIDSA; John V. Williams, MD; Natasha B. Halasa, MD, MPH, FPIDS
    742
    “Troponin leaks” in patients with acute respiratory Viral Infections enrolled in SUPERNOVA: a marker of worse clinical outcomes
    Ernesto Ruiz, MD; Bashir Lengi, MD; Tiffany Gray, RN; Mahwish Mushtaq, MD; Daniel Musher, MD, FIDSA; Maria Rodriguez-Barradas, MD, FIDSA
    743
    Severity and Costs of Respiratory Syncytial Virus and Bronchiolitis Hospitalization in Commercially Insured Preterm and Term Infants Before and After the 2014 American Academy of Pediatrics Guidance Change on Immunoprophylaxis
    Leonard R. Krilov, MD; Jaime Fergie, MD; Mitchell Goldstein, MD; Christopher Rizzo, MD; Lance Brannman, PhD; Jeffrey McPheeters, BA; Stephanie Korrer, MPH; Tanya Burton, PhD; Lucie Sharpsten, PhD
    744
    Effectiveness of 23-valent pneumococcal polysaccharide vaccine and influenza vaccine against pneumococcal pneumonia among elderly patients aged 65 years and older in the Republic of Korea : a case-control study
    Jong Hun Kim, MD; Byung Chul Chun, M.D., Ph.D.; Joon Young Song, MD; Hyo Youl Kim, MD, PhD; In-Gyu Bae, MD; Dong-Min Kim, MD; Won Suk Choi, MD, PhD; Y.H. Jeong, MD; Young Hwa Choi, MD, PhD; Seong Hui Kang, MD; Young Kyung Yoon, MD., Ph.D; Jang-Wook Sohn, MD., Ph.D.; Min-Ja Kim, MD., Ph.D
    745
    Surveillance for oseltamivir-resistant influenza A(H1N1)pdm09 virus infections during 2016-2017 and 2017-18, United States
    Sarah Spencer, PhD; Ha Nguyen, PhD; Anwar Abd Elal, BS; Jennifer Laplante, PhD; Kirsten St. George, MD; Alicia M. Fry, MD, MPH; Larisa Gubareva, MD, PhD; Angela P. Campbell, MD, MPH, FPIDS, FIDSA
    746
    Characteristics of Respiratory Syncytial Virus (RSV) Infection among Hospitalized Adults — United States, 2014–2017
    Lindsay Kim, MD, MPH; Bryanna Cikesh, MPH; Pam Daily Kirley, MPH; Evan J. Anderson, MD; Seth Eckel, MPH; Kathryn Como-Sabetti, MPH; Elizabeth M. Dufort, MD; Christina B. Felsen, MPH; Courtney Crawford, MPH; H. Keipp Talbot, MD, MPH; Gayle E. Langley, MD, MPH; Susan I. Gerber, MD
    747
    Antibiotic therapy for community-acquired pneumonia: a systematic review and network meta-analysis of randomized trials
    Reed Siemieniuk, MD, PhD(c); Yung Lee, BHSc; Isaac Bogoch, MD; Romina Brignardello-Petersen, DDS MSc PhD; Yutong Fei, MD PhD; Paul Alexander, PhD; Theresa Aves, RN MSc; Dena Zeraatkar, BHSc; Behnam Sadeghirad, PharmD MPH; Xun Li, MD; Nathan Evaniew, MD PhD; Neera Bhatnagar, MLIS; Bram Rochwerg, MD MSc; Gordon Guyatt, MD MSc; Mark Loeb, MD, MSc
    748
    The Impact of a Positive Respiratory Viral Panel among Hospitalized Adult Patients with Negative Rapid Influenza Testing at an Academic Tertiary Care Facility: A Matched Cohort Study
    Emily Ciccone, MD, MHS; Alan Kinlaw, PhD; Vahini Chundi, MD; Melissa Miller, PhD; David Weber, MD, MPH; Jonathan Juliano, MD, MSPH; Ravi Jhaveri, MD; Zachary Willis, MD, MPH
    749
    Healthcare Utilization After Hospitalization for Respiratory Syncytial Virus or Unspecified Bronchiolitis in the First Year of Life
    Joel Ledbetter, MD; Lance Brannman, PhD; Sally Wade, MPH; David Diakun, BS; Tara Gonzales, MD; Amanda Kong, MPH
    750
    Respiratory Virus Infections and Airflow Obstruction after Allogeneic Hematopoietic Cell Transplantation
    Michael Boeckh, MD, PhD, FIDSA; Angela P. Campbell, MD, MPH, FPIDS, FIDSA; Guang-Shing Cheng, MD; Hu Xie, MS; Jane Kuypers, PhD; Cheryl Callais, BA; Alpana Waghmare, MD; Terry Stevens-Ayers, MS; Keith Jerome, MD, PhD; Jason Chien, MD; Wendy Leisenring, ScD; Janet Englund, MD, FIDSA
    Posters
  • 750_IDWPOSTER.pdf (636.3 kB)
  • 751
    Acute Respiratory Illness Hospitalizations Among Young Children — Multi-Center Viral Surveillance Network, United States, 2015–2016
    Brian Rha, MD, MSPH; Angela P. Campbell, MD, MPH, FPIDS, FIDSA; Darius McDaniel, MSPH; Rangaraj Selvarangan, PhD; Natasha Halasa, MD, MPH; Janet Englund, MD, FIDSA; Julie A. Boom, MD; Parvin H. Azimi, MD; Geoffrey A. Weinberg, MD, FIDSA, FPIDS; Mary A. Staat, M.D., M.P.H.; Monica N. Singer, MD, MPH; Leila C. Sahni, MPH; Monica McNeal, MS; Eileen J. Klein, MD, MPH; Christopher J. Harrison, M.D., FAAP, FPIDS; John V. Williams, MD; Joana Yu, MPH; Daniella Figueroa-Downing, MPH; Mila M. Prill, MSPH; Brett L. Whitaker, MS; Aaron T. Curns, MPH; Gayle E. Langley, MD, MPH; Daniel C. Payne, PhD, MSPH; Susan I. Gerber, MD

    CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™


    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.